30 Sep 2025

XBRANE BIOPHARMA AB (“XBRANE” OR THE “COMPANY”) HAS ACCORDING TO PREVIOUSLY ANNOUNCED INFORMATION RESOLVED TO CARRY OUT A DIRECTED ISSUE OF IN TOTAL 25,990,000 SHARES

10 Sep 2025

NOTICE OF EXTRA GENERAL MEETING IN XBRANE BIOPHARMA AB

26 Aug 2025

Xbrane Biopharma releases Interim Report for January-June 2025

21 Aug 2025

Invitation to presentation of Xbrane Biopharma’s interim report January – June 2025 on August 26, 2025

31 Jul 2025

Xbrane Biopharma AB (“Xbrane” or the “Company”) has according to previously announced information resolved to carry out a directed issue of in total 1,017,488,260 shares.

11 Jul 2025

Xbrane publishes disclosure document regarding admission to trading of the newly issued shares in Xbrane

03 Jul 2025

Announcement from extra general meeting in Xbrane Biopharma AB

10 Jun 2025

NOTICE OF EXTRA GENERAL MEETING IN XBRANE BIOPHARMA AB

10 Jun 2025

Xbrane has, subject to the approval by an EGM, resolved to carry out an oversubscribed directed issue of shares of approximately SEK 240 million